Frank G. Pilkiewicz
- Molecular Biology
- Organic Chemistry top 10%
- Biomaterials top 10%
- Oncology
- Pulmonary and Respiratory Medicine
- Co-authors
- Michael J. PetteiKoji NakanishiIsao KuboKōji NakanishiRobert A. MossRomán Pérez-SolerPieter R. CullisKasper van der Born
- Topics
- Nanoparticle-Based Drug Delivery (4 papers)Lung Cancer Research Studies (3 papers)N-Heterocyclic Carbenes in Organic and Inorganic Chemistry (3 papers)
- Journals
- Journal of the American Chemical SocietyJournal of Clinical OncologyClinical Cancer Research
- Partner nations
- United StatesKenyaNetherlands
In The Last Decade
Frank G. Pilkiewicz
17 papers receiving 773 citations
Peers
Comparison fields: 5 of 92
- Molecular Biology 259
- Organic Chemistry 197
- Biomaterials 157
- Oncology 152
- Pulmonary and Respiratory Medicine 143
Countries citing papers authored by Frank G. Pilkiewicz
This map shows the geographic impact of Frank G. Pilkiewicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank G. Pilkiewicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank G. Pilkiewicz more than expected).
Fields of papers citing papers by Frank G. Pilkiewicz
This network shows the impact of papers produced by Frank G. Pilkiewicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank G. Pilkiewicz. The network helps show where Frank G. Pilkiewicz may publish in the future.
Co-authorship network of co-authors of Frank G. Pilkiewicz
This figure shows the co-authorship network connecting the top 25 collaborators of Frank G. Pilkiewicz. A scholar is included among the top collaborators of Frank G. Pilkiewicz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank G. Pilkiewicz. Frank G. Pilkiewicz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 134 | |
| 2 | 6 | |
| 3 | 0 | |
| 4 | 14 | |
| 5 | 34 | |
| 6 | Preclinical toxicology study of liposome encapsulated doxorubicin (TLC D-99): comparison with doxorubicin and empty liposomes in mice and dogs. | 40 |
| 7 | Initial clinical (phase I) trial of TLC D-99 (doxorubicin encapsulated in liposomes). | 112 |
| 8 | 45 | |
| 9 | Comparison of the cardiotoxic effects of liposomal doxorubicin (TLC D-99) versus free doxorubicin in beagle dogs. | 51 |
| 10 | 82 | |
| 11 | 24 | |
| 12 | 43 | |
| 13 | 14 | |
| 14 | 40 | |
| 15 | 121 | |
| 16 | 28 | |
| 17 | 5 | |
| 18 | 41 |
About Frank G. Pilkiewicz
Frank G. Pilkiewicz is a scholar working on Biomaterials, Biophysics and Pharmaceutical Science, having authored 18 papers that have together received 834 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (4 papers), Lung Cancer Research Studies (3 papers) and N-Heterocyclic Carbenes in Organic and Inorganic Chemistry (3 papers). The work is most often cited by research in Pharmaceutical Science (78 citations), Biomaterials (157 citations) and Biotechnology (67 citations). Frank G. Pilkiewicz has collaborated with scholars based in United States, Kenya and Netherlands. Frequent co-authors include Michael J. Pettei, Koji Nakanishi, Isao Kubo, Kōji Nakanishi, Robert A. Moss, Román Pérez-Soler, Pieter R. Cullis, Kasper van der Born, Pieter E. Postmus and Godefridus J. Peters. Their work appears in journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.